Skip to content

Clinical trials

Phase 3 Cerebral Palsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebral Palsy Phase: Phase 3 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20112
20124
20141
20151
20181
20192
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan4
Ipsen2
Teva Branded Pharmaceutical Products R&D, Inc.2
Columbia University1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Merz Pharmaceuticals GmbH1
Neurocrine Biosciences1
New York Medical College1
Shionogi1
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebral Palsy17
Muscle Spasticity8
Stroke3
Intellectual Disability2
Leukomalacia, Periventricular2
Sialorrhea2
Abruptio Placentae1
Athetosis1
Brain Injuries1
Chorea1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.